SeaStar Medical Holding Corp Share Price Today: Live Updates & Key Insights

SeaStar Medical Holding Corp share price today is $2.25, up -1.76%. The stock opened at $2.25 against the previous close of $2.27, with an intraday high of $2.27 and low of $2.09.

SeaStar Medical Holding Corp Share Price Chart

SeaStar Medical Holding Corp

us-stock
To Invest in {{usstockname}}
us-stock

SeaStar Medical Holding Corp Share Price Performance

$2.25 -0.0176(-1.76%) ICU at 23 Mar 2026 01:34 PM Biotechnology
Lowest Today 2.09
Highest Today 2.27
Today’s Open 2.25
Prev. Close 2.27
52 Week High 25.70
52 Week Low 2.09
Day’s Range: Low 2.09 High 2.27
52-Week Range: Low 2.09 High 25.70
1 day return -
1 Week return -12.19
1 month return -9.95
3 month return +719.83
6 month return +118.46
1 year return -1.16
3 year return -95.87
5 year return -99.13
10 year return -

SeaStar Medical Holding Corp Institutional Holdings

Vanguard Group Inc 0.99

Abante Quant Value FI 0.73

Vanguard Institutional Extnd Mkt Idx Tr 0.63

Fidelity Extended Market Index 0.56

Trinity Financial Advisors, LLC 0.20

NT Ext Equity Mkt Idx Fd - L 0.17

Spartan Extended Market Index Pool F 0.16

XTX Topco Ltd 0.13

Fidelity Series Total Market Index 0.07

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.07

The Toronto-Dominion Bank 0.07

Spartan Total Market Index Pool G 0.06

Fidelity Total Market Index 0.06

The Goldman Sachs Group Inc 0.05

Tyche Wealth Partners LLC 0.05

PNC Financial Services Group Inc 0.05

Northern Trust Corp 0.03

UBS Group AG 0.03

GREAT VALLEY ADVISOR GROUP, INC. 0.03

Northern Trust Extended Eq Market Idx 0.02

BlackRock Inc 0.02

Blackrock Extended Mkt Fund CF 0.02

Extended Equity Market Fund K 0.02

Fidelity Nasdaq Composite Index 0.01

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Advisor Group Holdings, Inc. 0.01

Goss Wealth Management LLC 0.00

Vanguard U.S. Eq Idx £ Acc 0.00

Extended Equity Market Fund M 0.00

Morgan Stanley - Brokerage Accounts 0.00

Bank of America Corp 0.00

TD Waterhouse Canada Inc 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

SBI Securities Co Ltd 0.00

TSFG, LLC 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

SOA Wealth Advisors, LLC. 0.00

Tower Research Capital LLC 0.00

SeaStar Medical Holding Corp Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

SeaStar Medical Holding Corp Fundamentals

Market Cap 8.47 M

PB Ratio 0.7524

PE Ratio 0.0

Enterprise Value 3.69 M

Total Assets 4.66 M

Volume 125669

SeaStar Medical Holding Corp Company Financials

Annual Revenue FY24:null 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY24:-26232000 -26.2M, FY23:-35572000 -35.6M, FY22:-23013000 -23.0M, FY21:-4596000 -4.6M, FY20:-3276000 -3.3M

Quarterly Revenue Q3/2025:183000 0.2M, Q2/2025:338000 0.3M, Q1/2025:293000 0.3M, Q3/2024:68000 0.1M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:169000 0.2M, Q2/2025:311000 0.3M, Q1/2025:293000 0.3M, Q3/2024:68000 0.1M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-3472000 -3.5M, Q2/2025:-2002000 -2.0M, Q1/2025:-3772000 -3.8M, Q3/2024:-4478000 -4.5M, Q2/2024:-3236000 -3.2M

About SeaStar Medical Holding Corp & investment objective

Company Information SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Organisation Biotechnology

Employees 19

Industry Biotechnology

CEO Mr. Eric Schlorff

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

SeaStar Medical Holding Corp FAQs

What is the share price of SeaStar Medical Holding Corp today?

The current share price of SeaStar Medical Holding Corp is $2.25.

Can I buy SeaStar Medical Holding Corp shares in India?

Yes, Indian investors can buy SeaStar Medical Holding Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy SeaStar Medical Holding Corp shares in India?

You can easily invest in SeaStar Medical Holding Corp shares from India by:

Can I buy fractional shares of SeaStar Medical Holding Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SeaStar Medical Holding Corp?

SeaStar Medical Holding Corp has a market cap of $8.47 M.

In which sector does SeaStar Medical Holding Corp belong?

SeaStar Medical Holding Corp operates in the Biotechnology sector.

What documents are required to invest in SeaStar Medical Holding Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of SeaStar Medical Holding Corp?

The PE ratio of SeaStar Medical Holding Corp is N/A and the PB ratio is 0.75.